Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chiara Ronchini

7PUBLICATIONS
7CO-AUTHORS
Haematological tumoursImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Aug 09, 2024
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid Leukemia.

Chiara Ronchini, Federica Gigli, Martina Fontanini

|Jan 10, 2024
High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients.

Chiara Ronchini, Chiara Caprioli, Gianleo Tunzi

|Jun 13, 2022
Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomes.

Elisabetta Todisco, Federica Gigli, Chiara Ronchini

|Jan 31, 2022
Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs.

Chiara Ronchini, Sara Gandini, Sebastiano Pasqualato

|Aug 29, 2020
Clinical presentation, diagnosis and management of therapy-related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly-ADP-ribose polymerase inhibitors: A single-center experience.

Elisabetta Todisco, Federica Gigli, Mara Mantiero

|May 05, 2020
Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia.

Elisabetta Todisco, Federica Gigli, Simona Sammassimo

Pageof 2

Frequent Collaborators

1 joint publications

Sara Gandini

1 joint publications

Sebastiano Pasqualato

1 joint publications

Francesco Bertolini

1 joint publications

Martina Fontanini

1 joint publications

Viviana Amato

1 joint publications

Francesco Lanza

1 joint publications

Enrico Derenzini

Frequent Collaborators

1 joint publications

Sara Gandini

1 joint publications

Sebastiano Pasqualato

1 joint publications

Francesco Bertolini

1 joint publications

Martina Fontanini

Top Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

24.3K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on : Jul 11, 2019

7.4K
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays

Published on : Feb 24, 2023

1.8K
See more related videos

Top Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

24.3K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on : Jul 11, 2019

7.4K
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays

Published on : Feb 24, 2023

1.8K
See more related videos